Patent details

EP3785733 Title: PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3785733
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP20195373.4
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
06/11/2018
Grant date:
05/01/2022
EP Publication Date:
03/03/2021
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
01/04/2022
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/01/2022
EP B1 Publication Date:
05/01/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/11/2038
Lapsed By Expiration Date:
Patent Validated Date:
16/04/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
05/01/2022
 
 

 

Name:
Stalicla S.A.
Address:
Avenue de Sécheron 15, 1202 Geneva, Switzerland (CH)

Agent

Name:
mr. R. Zwamborn
From:
15/04/2022
Address:
Huisman Advocaten Postbus 130, 4460 AC, Goes, Netherlands (NL)
To:

Inventor

Name:
Durham, Lynn
Address:
1202 Genève, Switzerland (CH)

Priority

1

Priority Patent Number:
201862663647 P
Priority Date:
27/04/2018
Priority Country:
United States of America (US)

2

Priority Patent Number:
201762582141 P
Priority Date:
06/11/2017
Priority Country:
United States of America (US)

3

Priority Patent Number:
18169952
Priority Date:
27/04/2018
Priority Country:
European Patent Office (EPO) (EP)

4

Priority Patent Number:
17200219
Priority Date:
06/11/2017
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 45/00; A61P 25/00; A61K 31/196; A61K 31/437;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
16/22
Publication date:
20/04/2022
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
01/22
Publication date:
05/01/2022
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202201
Publication date:
05/01/2022
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/11/2025
Annual Fee Number:
8
Annual Fee Amount:
280 Euro
Last Annual Payment Date:
20/11/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
220 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
15/04/2022 Outgoing Correspondence Letter no formal defects 1 PDF /7/6/5/9/5/0800759567/docs/ep20195373.4_0_474415l271.pdf
01/04/2022 Claims First filed claims 1 PDF /7/6/5/9/5/0800759567/docs/ep20195373.4_1_claims20220401134512116.pdf